Dr. Otar Datiashvili, MD

Dr. Datiashvili practices at IU Health Paoli Hospital in Paoli, Indiana, part of Indiana University Health.

Dr. Datiashvili's NPI, 1083096572, was assigned on June 22, 2015. Dr. Datiashvili graduated from State University of New York at Stony Brook, School of Medicine in 2008. Dr. Datiashvili holds Indiana license 01093706A.

Dr. Datiashvili's primary practice is IU Health Paoli Hospital, at 642 W Hospital Rd, Paoli, IN 47454 in Orange County. The practice phone is (812) 723-2811.

Dr. Datiashvili's primary practice is IU Health Paoli Hospital in Paoli, Indiana, part of Indiana University Health. Dr. Datiashvili is also affiliated with Methodist University Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Datiashvili to 3 more hospitals, 13 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Datiashvili practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Datiashvili's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Datiashvili's licenses on file in 2 states: Indiana and New York.

CMS data shows 285 Medicare services from Dr. Datiashvili across 3 procedure codes in 2024, for 287 Medicare patients. Medicare paid $32,270 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Datiashvili in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Datiashvili's median patient age at 45, with 55% women.

In 2024, Dr. Datiashvili wrote 159 Medicare Part D claims for 113 patients. 96% of them were for generic drugs. CMS names the drug for 113 of them, across 8 drugs with 11 or more claims each, at $998 in total drug cost. In 2023, CMS named 203 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Datiashvili for performance year 2024, reported through an alternative payment model (APM). Dr. Datiashvili accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Datiashvili graduated from State University of New York at Stony Brook, School of Medicine in 2008.